No profile data available.
Biocept, Inc. (BIOCQ) is a healthcare company in the additional medical testing equipment industry, based in San Diego, United States, with about 50 full-time employees.
It reported revenue of $25.86 million for fiscal year 2022, down 57.8% from fiscal year 2021, and net income of -$32.09 million. In Q2 2023 (the quarter ended June 30, 2023) revenue was $589,000, down 89.9% from a year before. Its market capitalization was $525 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2022; market data as of October 8, 2026.
, a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States.
Biocept reported $25.86 million in revenue for fiscal year 2022, down 57.8% from $61.25 million in fiscal year 2021. In Q2 2023 revenue was $589,000.
$525 as of October 8, 2026.
Listed companies of a similar size in the same industry (additional medical testing equipment) include Integrative Health Technologies, Inc. (IHTI), Response Genetics, Inc (RGDXQ), Rosetta Genomics Ltd. (ROSGQ), HTG Molecular Diagnostics, Inc. (HTGMQ).